Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Arterial Occlusive Diseases
Description
Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. MeSH
Hierarchy View
Subtype Terms (13)
Arteriosclerosis
29 drugs (22 approved, 7 experimental)
Carotid Stenosis
55 drugs (40 approved, 15 experimental)
Leriche Syndrome
1 approved drug
Median Arcuate Ligament Syndrome
Moyamoya Disease
6 drugs (5 approved, 1 experimental)
Popliteal Artery Entrapment Syndrome
1 approved drug
Renal Artery Obstruction
18 drugs (13 approved, 5 experimental)
Retinal Artery Occlusion
8 drugs (6 approved, 2 experimental)
Thromboangiitis Obliterans
9 drugs (3 approved, 6 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (15)
Phase 3 Indicated Drugs (34)
Phase 2 Indicated Drugs (19)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 3 Indications (31)
Organization Involved with Phase 2 Indications (30)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
